Tech Company Financing Transactions
Entia Funding Round
Entia closed a $20.6 million Series A investment round on 7/27/2023. Backers included Business Growth Fund and ParkWalk Advisors.
Transaction Overview
Company Name
Announced On
7/27/2023
Transaction Type
Venture Equity
Amount
$20,550,000
Round
Series A
Investors
Business Growth Fund (Lead Investor)
ParkWalk Advisors (Lead Investor)
Proceeds Purpose
The company will use the funds to expand its at-home blood testing for cancer patients, aiming to streamline patient monitoring and improve treatment outcomes across the UK and, potentially, the US.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
60 Gray's Inn Road
London, England, WC1X 8LU
UK
London, England, WC1X 8LU
UK
Phone
Website
Email Address
Overview
Entia is making life better for people receiving cancer treatment. We develop a range of virtual oncology solutions comprising novel self-testing blood analysers, apps and digital health solutions that seamlessly integrate with healthcare systems. Our ambitious team works on patient-centric designs, innovative technology and cutting edge medical science. Through these, we are redefining cancer care to empower patients and physicians, and benefit the wider global healthcare community.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Toby Fisher
Chief Financial Officer
Caroline Bailes
Chief Technical Officer
Chris Burrows
Browse more venture capital transactions:
Prev: 7/27/2023: ECO Group venture capital transaction
Next: 7/27/2023: Veir venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs